IsoRay Inc

Type: Company
Name: IsoRay Inc
First reported 1 hour ago - Updated 1 hour ago - 1 reports

C4 Imaging Announces First Sirius(TM) Positive Signal MRI Marker Implant

(NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- C4 Imaging LLC is pleased to announce the first patient implant with Sirius™, its novel positive-signal MRI Marker. Sirius™ is used following treatment of prostate cancer with brachytherapy ... [Published NewsRX - 1 hour ago]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

C4 Imaging Announces First Sirius™ Positive Signal MRI Marker Implant

By a News Reporter-Staff News Editor at Cancer Weekly -- C4 Imaging LLC is pleased to announce the first patient implant with Sirius™, its novel positive-signal MRI Marker. Sirius™ is used following treatment of prostate cancer with brachytherapy to facilitate ... [Published 4 Traders - Apr 17 2014]
First reported Apr 07 2014 - Updated Apr 08 2014 - 6 reports

First Human Prostate Implant Uses IsoRay’s Cesium-131 Seeds and C4’s Sirius MRI Markers

The first-in-human prostate implant of IsoRay’s Cesium-131 radioactive seeds using C4 Imaging’s positive signal MRI markers was conducted at MD Anderson Cancer Center in Houston, Texas, the company said Monday.Implanting physician Steven Frank said the ... [Published FDA News - Apr 08 2014]
First reported Apr 07 2014 - Updated Apr 07 2014 - 3 reports

Data Review on Active Stocks -- Research on Procter & Gamble, Halozyme Therapeutics, Symantec, and IsoRay

-- /PRNewswire/ --The trading session on Friday, April 04, 2014 ended on a lower note as the Dow Jones Industrial Average finished at 16,412.71, down 0.96% and the NASDAQ Composite closed at 4,127.73, down 2.60%. The S&P 500 finished the session 1.25% ... [Published Sacramento Bee - Apr 07 2014]
First reported Apr 04 2014 - Updated Apr 04 2014 - 2 reports

Biotech Stock Mailbag: Celgene, IsoRay, Northwest Bio, Bubble Worries

If your browser does not automatically forward you to http://business-news.thestreet.com/philly/story/biotech-stock-mailbag-celgene-isoray-northwest-bio-bubble-worries/12615741, please click here. ... [Published Philly.com - Apr 04 2014]
First reported Apr 03 2014 - Updated Apr 04 2014 - 2 reports

IsoRay (ISR) Builds on Conference Momentum

If your browser does not automatically forward you to http://business-news.thestreet.com/philly/story/isoray-isr-builds-on-conference-momentum/12621596, please click here. ... [Published Philly.com - Apr 04 2014]
Entities: IsoRay Inc
First reported Apr 01 2014 - Updated Apr 01 2014 - 4 reports

IsoRay (ISR) Spikes Again on Announcement of Presentations at Weekend Conference

Shares in small-cap health care company IsoRay (ISR) took off again on Tuesday after announcing plans to present five papers at the upcoming Annual Meeting of the American Brachytherapy Society (ABS)."IsoRay is pleased to once again participate at the ... [Published Equities.com - Apr 01 2014]
First reported Mar 26 2014 - Updated Mar 27 2014 - 7 reports

IsoRay Inc closes registered direct offering

registered direct placement of 5,644,300 shares of common stock at price of $2.60 per share with two institutional investors.Intends to use net proceeds for working capital and general corporate purposes.Maxim Group LLC acted as exclusive placement agent ... [Published Reuters - Mar 27 2014]
First reported Mar 24 2014 - Updated Mar 25 2014 - 2 reports

IsoRay (ISR) Continues Fall on Heavy Volume

If your browser does not automatically forward you to http://business-news.thestreet.com/philly/story/isoray-isr-continues-fall-on-heavy-volume/12541201, please click here. ... [Published Philly.com - Mar 25 2014]
Entities: IsoRay Inc
First reported Mar 20 2014 - Updated Mar 21 2014 - 8 reports

IsoRay drops hard on news of $14.7M direct offering

by IsoRay's stock drops more than 20% after the company sells nearly $14.7 million of its common stock to institutional investors.Wall Street give IsoRay Medical's  (AMEX: ISR ) shares a beating today after the company announced that it had sold about ... [Published MassDevice - Mar 21 2014]
First reported Mar 19 2014 - Updated Mar 20 2014 - 4 reports

Will IsoRay (ISR) Continue Its Surge

NEW YORK (TheStreet) -- Shares of medical company IsoRay  continue to skyrocket Thursday on the news of a breakthrough in tumor treatment. The Washington State-based company was up 23.5% to $3.13 in early trading Thursday.The patient -- a 12 year old ... [Published The Street Latest - Mar 20 2014]
First reported Mar 19 2014 - Updated Mar 20 2014 - 7 reports

IsoRay shares soar on cancer treatment news

Shares in IsoRay Inc. soared on Wednesday on news that the company's cancer treatment was used successfully on a 12-year-old patient.Shares in Richland, Wash.-based IsoRay (NYSE: ISR) jumped more than 133 percent on Wednesday, rising $1.46 to close at ... [Published Puget Sound Business Journal - Mar 20 2014]

Quotes

IsoRay CEO Dwight Babcock commented, "We are very excited to have our Cesium-131 isotope seeds chosen to partner with C4 Imaging's innovative positive-signal MRI Markers in the treatment of prostate cancer. This combines two of the newest technologies available in brachytherapy with the goal of improving patient outcomes."
...with C4 Imaging's innovative positive signal MRI markers in the treatment of prostate cancer," said IsoRay CEO Dwight Babcock in a statement. "By combining two of the newest technologies available in brachytherapy, we hope to demonstrate superior outcomes with the goal of improving patient lives. As we continue to develop our product offerings both internally and in partnership with other industry leaders, our message is clear and the medical community is becoming increasingly aware of the innovative alternative our Cesium-131 products offer to cancer patients."
...Steven Frank of the Anderson Cancer Center, who performed the implant, said that with its short half-life, Cesium-131 "offers rapid resolution of the acute side effects that can be associated with prostate treatment with brachytherapy" . IsoRay's technology enables doctors to directly place radiation in areas where cancer is most likely to remain after a tumor is removed. ( PR )
Dr Frank further stated "Strands utilizing IsoRay's Cesium-131 seeds and C4 Imaging's Sirius ®"

More Content

All (104) | News (94) | Reports (0) | Blogs (8) | Audio/Video (0) | Fact Sheets (0) | Press Releases (2)
sort by: Date | Relevance
C4 Imaging Announces First Sirius(TM) Positive ... [Published NewsRX - 1 hour ago]
C4 Imaging Announces First Sirius™ Positive Sig... [Published 4 Traders - Apr 17 2014]
IsoRay (ISR) Trips After Strong Monday Run [Published The Street Latest - Apr 08 2014]
IMMU Chugs Along, MNKD Decision Delayed, QCOR B... [Published RTTNews.com - Apr 08 2014]
First Human Prostate Implant Uses IsoRay’s Cesi... [Published FDA News - Apr 08 2014]
Why IsoRay (ISR) Stock Is Up Today [Published The Street Latest - Apr 07 2014]
Midday Update: Lackluster Q1 Earnings Forecasts... [Published Nasdaq - Apr 07 2014]
Morning Market Movers [Published Benzinga.com - Apr 07 2014]
IsoRay seeds implanted into human prostate for ... [Published Seeking Alpha - Apr 07 2014]
IsoRay Announces World's First Human Prostate I... [Published Marketwire - Breaking News Releases - Apr 07 2014]
IsoRay Announces World's First Human Prostate I... [Published eTeligis - Apr 07 2014]
Data Review on Active Stocks -- Research on Pro... [Published Sacramento Bee - Apr 07 2014]
Data Review on Active Stocks -- Research on Pro... [Published Sys-Con Italia - Apr 07 2014]
Data Review on Active Stocks -- Research on Pro... [Published Michigan Live - Apr 07 2014]
C4 Imaging Announces First Sirius™ Positive Si... [Published TickerTech.com - Apr 07 2014]
Data Review on Active Stocks -- Research on Pro... [Published FinanzNachrichten.de - Apr 07 2014]
Data Review on Active Stocks -- Research on Pro... [Published Digital Journal - Apr 07 2014]
Data Review on Active Stocks -- Research on Pro... [Published TickerTech.com - Apr 07 2014]
Data Review on Active Stocks -- Research on Pro... [Published Financial Services - Apr 07 2014]
Biotech Stock Mailbag: Celgene, IsoRay, Northwe... [Published Philly.com - Apr 04 2014]
Analysts' Actions: ANF APC DIS GME SNI [Published The Street Latest - Apr 04 2014]
Biotech Stock Mailbag: Celgene, IsoRay, Northwe... [Published The Street Latest - Apr 04 2014]
IsoRay (ISR) Builds on Conference Momentum [Published Philly.com - Apr 04 2014]
IsoRay (ISR) Builds on Conference Momentum [Published The Street Latest - Apr 03 2014]
Strong Session Stocks: MannKind Corp (Nasdaq:MN... [Published Galaxy Stocks - Apr 03 2014]
First-quarter winners of market-guessing compet... [Published Seattle Times - Apr 02 2014]
Stock Analysts’ Price Target Changes for April,... [Published American Banking News - Apr 02 2014]
S&P Hits All-Time Record High, DJIA Comes Close [Published HispanicBusiness.com - Apr 01 2014]
Top 10 Penny Stocks for March: Gains Near 2,000% [Published Money Morning - Apr 01 2014]
Healthcare Review: Tonix Pharmaceuticals, Gilea... [Published BioMedReports - Apr 01 2014]
1 2 3 4
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
IsoRay Announces World's First Human Prostate I... [Published Marketwire - Breaking News Releases - Apr 07 2014]
Dr. Steven Frank of MD Anderson Performed the First Implant ...
IsoRay Announces Five Presentations at the Amer... [Published Marketwire - Breaking News Releases - Apr 01 2014]
Oral Presentations and Posters on Various Studies Utilizing Cesium-131 Will Be at Center Stage ...
IsoRay, Inc. Closes $14,675,180 Registered Dire... [Published Marketwire - Breaking News Releases - Mar 27 2014]
RICHLAND, WA--(Marketwired - Mar 27, 2014) - IsoRay, Inc. (NYSE MKT: ISR) announced today that it closed on a $14,675,180 registered direct placement (the "Offering") of 5,644,300 shares of common stock at a price of $2.60 per share with two institutional ...
IsoRay, Inc. Prices Registered Direct Offering ... [Published Marketwire - Breaking News Releases - Mar 21 2014]
RICHLAND, WA--(Marketwired - Mar 21, 2014) -  IsoRay, Inc. (NYSE MKT: ISR) announced today that it has entered into definitive agreements with two institutional investors to sell 5,644,300 shares of common stock at a price of $2.60 per share. The gross ...
IsoRay Announces World's First Pediatric Cesium... [Published Marketwire - Breaking News Releases - Mar 19 2014]
Cesium-131 Implants Used to Provide Needed Radiation to Treat This Aggressive Cancer ...
1 2

Press Releases

sort by: Date | Relevance
Data Review on Active Stocks -- Research on Pro... [Published Financial Services - Apr 07 2014]
Stock Market's Most Active: Synovus Financial, ... [Published Financial Services - Mar 18 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.